| Identification | Back Directory | [Name]
2,6-Dibromopyridine-4-carboxylic acid | [CAS]
2016-99-1 | [Synonyms]
2,6-Dibromoisonicotinic acid
2,6-DibroMopyridine-4-car...
2,6-Dibromopyridine-4-carboxylic
DibroMopyridine-4-carboxylic acid
2,6-DibroMoisonicotinic acid, 95+%
6-Dibromopyridine-4-carboxylic acid
2,6-Dibromopyridine-4-carboxylicaci
2,6-Dibromo-4-pyridinecarboxylic acid
2,6-Dibromopyridine-4-carboxylic acid
2,6-Dibromoopyridine-4-carboxylic acid
4-Pyridinecarboxylic acid, 2,6-dibromo-
Isonicotinicacid, 2,6-dibromo- (6CI,7CI,8CI)
2,6-Dibromopyridine-4-carboxylic acid ISO 9001：2015 REACH
2,6-Dibromopyridine-4-carboxylic acid, 4-Carboxy-2,6-dibromopyridine | [EINECS(EC#)]
640-910-0 | [Molecular Formula]
C6H3Br2NO2 | [MDL Number]
MFCD08741485 | [MOL File]
2016-99-1.mol | [Molecular Weight]
280.9 |
| Chemical Properties | Back Directory | [Melting point ]
184-185 °C(Solv: water (7732-18-5)) | [Boiling point ]
487.5±45.0 °C(Predicted) | [density ]
2.202±0.06 g/cm3(Predicted) | [storage temp. ]
Inert atmosphere,2-8°C | [form ]
solid | [pka]
2.59±0.10(Predicted) | [color ]
White to off white | [InChI]
InChI=1S/C6H3Br2NO2/c7-4-1-3(6(10)11)2-5(8)9-4/h1-2H,(H,10,11) | [InChIKey]
AULQTVXAKNKCCA-UHFFFAOYSA-N | [SMILES]
C1(Br)=NC(Br)=CC(C(O)=O)=C1 |
| Hazard Information | Back Directory | [Chemical Properties]
Pale yellow solid | [Uses]
2,?6-?Dibromopyridine-?4-?carboxylic Acid is an analog of 2,6-Dichloroisonicotinic acid which binds and inhibits tobacco catalase activity. | [Synthesis]
General procedure for the synthesis of 2,6-dibromopyridine-4-carboxylic acid from citrazinic acid: Citrazinic acid (2.33 g, 0.015 mol) was mixed with phosphorus tribromide and heated to 180 °C under nitrogen protection for 3 hours. After completion of the reaction, the reaction mixture was cooled and quenched carefully with ice water. The reaction mixture was filtered and the aqueous phase was extracted with dichloromethane (4 x 40 ml). The solid fraction was continuously extracted in a Soxhlet extractor using dichloromethane for 12 hours. The directly extracted organic phase was dried with anhydrous sodium sulfate, filtered and concentrated to give 2.2 g of slightly red solid. The organic phase of Soxhlet extraction was similarly dried with anhydrous sodium sulfate, filtered and concentrated to give 0.5 g of a slightly red solid. The two fractions of 2,6-dibromoisonicotinic acid (64% total yield) were combined after confirmation of structural identity by NMR hydrogen spectroscopy (CDCl3, δ 8.04, 2H, s). | [References]
[1] Journal of Medicinal Chemistry, 2013, vol. 56, # 12, p. 5079 - 5093
[2] Tetrahedron, 2007, vol. 63, # 2, p. 291 - 298
[3] Organic and Biomolecular Chemistry, 2005, vol. 3, # 8, p. 1460 - 1467
[4] Patent: WO2005/84439, 2005, A1. Location in patent: Page/Page column 35
[5] Synthesis, 2000, # 8, p. 1138 - 1142 |
|
|